USS Investment Management Ltd Acquires 34,600 Shares of CVS Health Corporation (CVS)

USS Investment Management Ltd grew its holdings in shares of CVS Health Corporation (NYSE:CVS) by 12.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 321,700 shares of the pharmacy operator’s stock after purchasing an additional 34,600 shares during the quarter. USS Investment Management Ltd’s holdings in CVS Health Corporation were worth $25,892,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in CVS. Boston Partners raised its holdings in shares of CVS Health Corporation by 69.1% during the 2nd quarter. Boston Partners now owns 6,459,237 shares of the pharmacy operator’s stock valued at $519,711,000 after purchasing an additional 2,638,888 shares in the last quarter. Prudential Financial Inc. raised its holdings in shares of CVS Health Corporation by 61.8% during the 2nd quarter. Prudential Financial Inc. now owns 2,946,531 shares of the pharmacy operator’s stock valued at $237,078,000 after purchasing an additional 1,125,400 shares in the last quarter. Canada Pension Plan Investment Board raised its holdings in shares of CVS Health Corporation by 89.8% during the 2nd quarter. Canada Pension Plan Investment Board now owns 1,851,099 shares of the pharmacy operator’s stock valued at $148,939,000 after purchasing an additional 876,027 shares in the last quarter. NN Investment Partners Holdings N.V. raised its holdings in shares of CVS Health Corporation by 141.2% during the 2nd quarter. NN Investment Partners Holdings N.V. now owns 1,427,210 shares of the pharmacy operator’s stock valued at $114,832,000 after purchasing an additional 835,476 shares in the last quarter. Finally, Swiss National Bank raised its holdings in shares of CVS Health Corporation by 26.9% during the 1st quarter. Swiss National Bank now owns 3,826,410 shares of the pharmacy operator’s stock valued at $300,373,000 after purchasing an additional 811,100 shares in the last quarter. Institutional investors and hedge funds own 81.46% of the company’s stock.

CVS has been the topic of a number of recent research reports. Royal Bank Of Canada initiated coverage on shares of CVS Health Corporation in a report on Tuesday, September 19th. They set an “outperform” rating and a $95.00 price target on the stock. Robert W. Baird restated a “hold” rating and set a $77.00 price target on shares of CVS Health Corporation in a report on Friday, October 27th. Loop Capital initiated coverage on shares of CVS Health Corporation in a research note on Thursday, August 24th. They issued a “hold” rating and a $83.00 target price on the stock. Jefferies Group LLC set a $86.00 target price on shares of CVS Health Corporation and gave the company a “hold” rating in a research note on Wednesday, October 18th. Finally, Wolfe Research lowered shares of CVS Health Corporation from an “outperform” rating to a “market perform” rating and lowered their target price for the company from $89.00 to $82.00 in a research note on Monday, August 14th. One analyst has rated the stock with a sell rating, nine have given a hold rating and fifteen have given a buy rating to the stock. CVS Health Corporation presently has an average rating of “Buy” and a consensus target price of $87.33.

TRADEMARK VIOLATION WARNING: This report was first posted by Community Financial News and is the property of of Community Financial News. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this report can be viewed at https://www.com-unik.info/2017/11/06/uss-investment-management-ltd-acquires-34600-shares-of-cvs-health-corporation-cvs.html.

Shares of CVS Health Corporation (NYSE CVS) opened at $69.25 on Monday. The company has a current ratio of 1.09, a quick ratio of 0.56 and a debt-to-equity ratio of 0.75. CVS Health Corporation has a 12-month low of $68.01 and a 12-month high of $84.72. The firm has a market cap of $70,397.13, a PE ratio of 11.84, a PEG ratio of 1.26 and a beta of 0.86.

CVS Health Corporation (NYSE:CVS) last issued its earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share for the quarter, beating the consensus estimate of $1.31 by $0.02. CVS Health Corporation had a net margin of 2.93% and a return on equity of 17.47%. The business had revenue of $45.69 billion for the quarter, compared to analyst estimates of $45.36 billion. During the same period in the previous year, the business earned $1.32 EPS. The firm’s revenue was up 4.5% on a year-over-year basis. analysts anticipate that CVS Health Corporation will post 5.88 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Friday, November 3rd. Stockholders of record on Tuesday, October 24th were given a dividend of $0.50 per share. The ex-dividend date was Monday, October 23rd. This represents a $2.00 annualized dividend and a dividend yield of 2.89%. CVS Health Corporation’s dividend payout ratio (DPR) is currently 39.92%.

In other news, Director Richard J. Swift sold 2,500 shares of CVS Health Corporation stock in a transaction dated Wednesday, August 16th. The shares were sold at an average price of $79.62, for a total transaction of $199,050.00. Following the sale, the director now directly owns 3,258 shares in the company, valued at approximately $259,401.96. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Thomas M. Moriarty sold 20,547 shares of CVS Health Corporation stock in a transaction dated Monday, October 2nd. The shares were sold at an average price of $81.17, for a total transaction of $1,667,799.99. Following the sale, the executive vice president now owns 43,178 shares in the company, valued at $3,504,758.26. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 716,625 shares of company stock worth $58,318,431. 0.61% of the stock is owned by company insiders.

CVS Health Corporation Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

What are top analysts saying about CVS Health Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for CVS Health Corporation and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit